Investigator's Brochure (IB) Table

Drugs

Vaccines

Vaccine Name Sort descending Vaccine Company IB Date Risk List Available?
10-1074-LS(-J) - New - New Rockefeller University/Celldex Therapeutics November 2024
16055 NFL Delta Gly4 Env Protein Trimer, Adjuvanted with 3M-052 AF + Alum DAIDS/NIAID/NIH December 2023
3BNC117-LS (-J) Rockefeller University/Celldex Therapeutics November 2024
3M-052-AF Access to Advanced Health Institute (AAHI) November 2023
426c.Mod.Core-C4b, Adjuvanted - New - New DAIDS/NIAID/NIH January 2025
AdC6-HIVgp140, AdC7-HIVgp140, CH505TF/GLA-SE Vaccines DAIDS/NIAID/NIH March 2021
BG505 SOSIP.664 gp140 DAIDS/NIAID/NIH April 2024
BG505 SOSIP.GT1.1 gp140 Vaccine International AIDS Vaccine Initiative (IAVI) January 2024
CD40.HIVRI.Env (VRIPRO) - New - New Vaccine Research Institute (VRI) November 2024
CD4BS CH505M5 Pr-NP1, Adjuvanted DAIDS/NIAID/NIH April 2024
CH505 TF chTrimer DAIDS/NIAID/NIH April 2024
CH505M5 N197D mRNA-gp160 and CH505 TF mRNA-gp160 Duke Human Vaccine Institute (DHVI) November 2024
ChAdOx1.HIVconsv62 University of Oxford May 2024
ChAdOx1.tHIVconsv1 - New - New University of Oxford December 2024
CMV-MVA Triplex - New - New City of Hope National Medical Center October 2024
DV700P-RNA and DV701B1.1-RNA - New - New Duke Human Vaccine Institute (DHVI) February 2025
EnvSeq-1 and EnvSeq-2 DAIDS/NIAID/NIH October 2022
GLA-SE Infectious Disease Research Institute (IDRI) May 2023
GS-2872 (10-1074 LS) - New - New Gilead Sciences January 2025
GS-5423 (3BNC117-LS) - New - New Gilead Sciences January 2025